伊卡里因作为乳腺癌治疗剂:调节亡并抑制扩散
Kavita Goyal1, Muhammad Afzal2, M Arockia Babu3
1Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun, India.
Journal of complementary & integrative medicine
|July 6, 2025
概括
伊卡林是一种天然化合物,通过向多个途径来抑制瘤生长和转移,显示出对乳腺癌的显著潜力. 对纳米配方和临床试验的进一步研究对于其治疗应用至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 自然产品 化学 化学
背景情况:
- 乳腺癌是全球癌症死亡的主要原因,需要新的治疗方法.
- 伊卡林是一种来自Epimedium物种的天然化合物,具有多重向的抗癌性质.
- 现有研究强调了icariin对关键致癌途径的调节和抗转移效应.
研究的目的:
- 系统地审查关于伊卡林在乳腺癌中的药理作用的临床前证据.
- 探索纳米配方的进步,以提高伊卡林的生物可用性.
- 识别知识差距并指导未来的临床翻译研究.
主要方法:
- 在乳腺癌模型中对伊卡林的体外和体内研究进行系统审查.
- 对伊卡林分子机制的分析,包括途径调制 (PI3K/Akt,MAPK,NF-κB/SIRT6,AMPK/mTOR).
- 对伊卡林对增殖,亡,自,转移和免疫调节的影响的评估.
主要成果:
- 伊卡林抑制乳腺癌细胞的增殖,诱导细胞亡,并调节自.
- 伊卡林通过抑制表皮细胞转化为介质酶的转变和矩阵金属蛋白酶的活性,显示出抗转移的潜力.
- 伊卡林具有免疫调节作用,可以增强抗瘤免疫力.
结论:
- 伊卡林是乳腺癌治疗的有前途的多目标药物.
- 纳米配方的进步对于提高伊卡林的生物可用性和治疗疗效至关重要.
- 需要进一步的研究,整合机械见解,配方科学和临床试验,以优化伊卡林在瘤学中的使用.
相关概念视频
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:38Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
02:15Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
01:31The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K